Improved focal liver lesion detection: Comparison of single-shot spin-echo echo-planar and Superparamagnetic Iron Oxide (SPIO)-enhanced MRI

Journal of Magnetic Resonance Imaging

Volumn 27, Issue 1, 2008, Pages 117-124

  Coenegrachts, Kenneth ^a   Orlent, Hans ^a   Ter Beek, Leon ^b   Haspeslagh, Marc ^c   Bipat, Shandra ^d   Stoker, Jaap ^d   Rigauts, Hans ^a  

^a Department of Radiology ^*  (Belgium)

^b PHILIPS HEALTHCARE   (United States)

^c Hospital Administration and Statistics   (Belgium)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Lesion; Liver; MRI; SPIO enhanced imaging; SSSE EPI

Indexed keywords

FERUCARBOTRAN; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CANCER; LIVER HEMANGIOMA; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE DIAGNOSIS; SINGLE SHOT SPIN ECHO ECHO PLANAR IMAGING;

COLORECTAL NEOPLASMS; CONTRAST MEDIA; ECHO-PLANAR IMAGING; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; WHOLE BODY IMAGING;

EID: 37849048271     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21247     Document Type: Article

References (20)

1. Bipat S, van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology 2005;237:123-131.
2. Morana G, Grazioli L, Testoni M, Caccia P, Procacci C. Contrast agents for hepatic magnetic resonance imaging. Top Magn Reson Imaging 2002;13:117-150.
3. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006;239:122-130.
4. Vogl TJ, Schwarz W, Blume S, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 2003;13:262-272.
5. Strotzer M, Gmeinwieswer J, Schmidt J, et al. Diagnosis of liver metastasis from colorectal adenocarcinoma: comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging. Acta Radiol 1997;38:986-992.
6. Reimer P, Jahnke N, Fiebich M, et al. Hepatic lesion detection and characterization: Value of nonenhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000;217:152-158.
7. Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 2006;16:1337-1345.
8. 2-weighted spin-echo echo-planar imaging sequence with sensitivity encoding replace the respiratory-triggered turbo spin-echo sequence for the liver? An optimization and feasibility study. J Magn Reson Imaging 2005;21:219-229.
9. 2w turbo spin echo techniques. Br J Radiol 2007;80:524-531.
10. Kehagias DT, Gouliamos AD, Smyrniotis V, Vlahos LJ. Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 2001;14:595-601.
11. Kim JH, Kim MJ, Suh SH, Chung JJ, Yoo HS, Lee JT. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 2002;15:573-583.
12. Grangier C, Tourniaire J, Mentha G, et al. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J Comput Assist Tomogr 1994;18:888-896.
13. Denys A, Arrive L, Servois V, et al. Hepatic tumors: Detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 1994;193:665-669.
14. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200:785-792.
15. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: Comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999;210:459-466.
16. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PI, Borel Rinkes IH, Wiggers T. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 1997;203:449-456.
17. Bross IDJ. How to use RIDIT analysis. Biometrics 1958;14:18-38.
18. Nagayama M, Watanabe Y, Okumura A, et al. Black-blood T2-weighted SE-EPI imaging of the liver. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, HI, USA, 2002 (Abstract 14).
19. Ward J, Feng C, Guthrie JA, et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 2000;214:159-166.
20. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-216.